Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma

被引:338
作者
Skobe, M
Hamberg, LM
Hawighorst, T
Schirner, M
Wolf, GL
Alitalo, K
Detmar, M
机构
[1] Massachusetts Gen Hosp, Dept Dermatol, CBRC, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Ctr Imaging & Pharmaceut Res, Charlestown, MA 02129 USA
[3] Harvard Univ, Sch Med, Charlestown, MA USA
[4] Schering AG, D-1000 Berlin, Germany
[5] Univ Helsinki, Haartman Inst, Helsinki, Finland
关键词
D O I
10.1016/S0002-9440(10)61765-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Interactions of tumor cells with lymphatic vessels are of paramount importance for tumor progression, however, the underlying molecular mechanisms are poorly understood. Whereas enlarged lymphatic vessels are frequently observed at the periphery of malignant melanomas, it has remained unclear whether intratumoral lymphangiogenesis occurs within these tumors. Here, we demonstrate the presence of intratumoral lymphatics and enlargement of lymphatic vessels at the tumor periphery in vascular endothelial growth factor (VEGF)-C-overexpressing human melanomas transplanted onto nude mice. VEGF-C expression also resulted in enhanced tumor angiogenesis, indicating a coordinated regulation of lymphangiogenesis and angiogenesis in melanoma progression. The specific biological effects of VEGF-C were critically dependent on its proteolytic processing in vivo. Furthermore, VEGF-C induced chemotaxis of macrophages in vitro and in vivo, revealing a potential function of VEGF-C as an immunomodulator. Taken together, our results identify VEGF-C as multifunctional factor involved in regulating tumor lymphangiogenesis, angiogenesis, and immune response.
引用
收藏
页码:893 / 903
页数:11
相关论文
共 70 条
  • [1] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [2] Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
    Akagi, K
    Ikeda, Y
    Miyazaki, M
    Abe, T
    Kinoshita, J
    Maehara, Y
    Sugimachi, K
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (07) : 887 - 891
  • [3] André T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO
  • [4] 2-5
  • [5] APRELIKOVA O, 1992, CANCER RES, V52, P746
  • [6] INTERSTITIAL-LYMPHATIC MECHANISMS IN THE CONTROL OF EXTRACELLULAR FLUID VOLUME
    AUKLAND, K
    REED, RK
    [J]. PHYSIOLOGICAL REVIEWS, 1993, 73 (01) : 1 - 78
  • [7] F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE
    AUSTYN, JM
    GORDON, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) : 805 - 815
  • [8] LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
    Banerji, S
    Ni, J
    Wang, SX
    Clasper, S
    Su, J
    Tammi, R
    Jones, M
    Jackson, DG
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 144 (04) : 789 - 801
  • [9] TRANSPORT OF FLUID AND MACROMOLECULES IN TUMORS .2. ROLE OF HETEROGENEOUS PERFUSION AND LYMPHATICS
    BAXTER, LT
    JAIN, RK
    [J]. MICROVASCULAR RESEARCH, 1990, 40 (02) : 246 - 263
  • [10] VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS
    BERSE, B
    BROWN, LF
    VANDEWATER, L
    DVORAK, HF
    SENGER, DR
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) : 211 - 220